Literature DB >> 16944313

Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.

Harun M Said1, Adrian Staab, Carsten Hagemann, Giles H Vince, Astrid Katzer, Michael Flentje, Dirk Vordermark.   

Abstract

The hypoxia-inducible enzyme carbonic anhydrase IX (CA IX) has recently been discussed as a surrogate marker of tumor hypoxia, an indicator of prognosis and a potential therapeutic target in malignant glioma. To characterize patterns of expression of CA IX in human malignant glioma cells, we studied CA IX protein, CA9 mRNA and hypoxia-inducible factor-1alpha (HIF-1alpha) protein levels in U87-MG, U251, U373 and GaMG cells exposed to in vitro hypoxia (1, 6 or 24 h at 5%, 1% or 0.1% O(2)). All cell lines displayed a strong hypoxic induction of CA9 mRNA in response to prolonged severe hypoxia with cell-line specific patterns at moderate to mild hypoxia and shorter treatment times. Only U87-MG exhibited a strong constitutive, normoxic expression of CA IX protein without a detectable change under hypoxia. In U251 and GaMG cell lines, a marked induction of CA IX protein in response to severe hypoxia was seen. CA IX changes under severe hypoxia and the inhibitory effect of the glycolysis inhibitor iodoacetate (IAA, 50 microM) on hypoxic CA IX overexpression were paralleled by the results for HIF-1alpha protein. Therefore, immunohistochemical CA IX staining in human malignant glioma specimens can result from low oxygen concentrations or constitutive, oncogene-related, overexpression both of which may be prognostically relevant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944313     DOI: 10.1007/s11060-006-9205-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  44 in total

1.  Hypoxia-inducible expression of tumor-associated carbonic anhydrases.

Authors:  C C Wykoff; N J Beasley; P H Watson; K J Turner; J Pastorek; A Sibtain; G D Wilson; H Turley; K L Talks; P H Maxwell; C W Pugh; P J Ratcliffe; A L Harris
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 2.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

3.  Expression of MaTu-MN protein in human tumor cultures and in clinical specimens.

Authors:  J Závada; Z Závadová; S Pastoreková; F Ciampor; J Pastorek; V Zelník
Journal:  Int J Cancer       Date:  1993-05-08       Impact factor: 7.396

4.  Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor.

Authors:  P J Kallio; I Pongratz; K Gradin; J McGuire; L Poellinger
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

5.  Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.

Authors:  Joonas A Haapasalo; Kristiina M Nordfors; Mika Hilvo; Immo J Rantala; Ylermi Soini; Anna-Kaisa Parkkila; Silvia Pastoreková; Jaromir Pastorek; Seppo M Parkkila; Hannu K Haapasalo
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

Review 6.  Genetic and hypoxic regulation of angiogenesis in gliomas.

Authors:  Balveen Kaur; Chalet Tan; Daniel J Brat; Dawn E Post; Erwin G Van Meir
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

7.  Hypoxia is important in the biology and aggression of human glial brain tumors.

Authors:  Sydney M Evans; Kevin D Judy; Isolde Dunphy; W Timothy Jenkins; Wei-Ting Hwang; Peter T Nelson; Robert A Lustig; Kevin Jenkins; Deirdre P Magarelli; Stephen M Hahn; Ruth A Collins; M Sean Grady; Cameron J Koch
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

8.  Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells.

Authors:  Dirk Vordermark; Anja Kaffer; Susanne Riedl; Astrid Katzer; Michael Flentje
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

9.  Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Authors:  D M Brizel; S P Scully; J M Harrelson; L J Layfield; J M Bean; L R Prosnitz; M W Dewhirst
Journal:  Cancer Res       Date:  1996-03-01       Impact factor: 12.701

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  12 in total

1.  Hypoxia and cytokines regulate carbonic anhydrase 9 expression in hepatocellular carcinoma cells in vitro.

Authors:  Feray Kockar; Hatice Yildrim; Rahsan Ilikci Sagkan; Carsten Hagemann; Yasemin Soysal; Jelena Anacker; Ahmed Ayad Hamza; Dirk Vordermark; Michael Flentje; Harun M Said
Journal:  World J Clin Oncol       Date:  2012-06-10

2.  Synergistic effects of arsenic trioxide and silibinin on apoptosis and invasion in human glioblastoma U87MG cell line.

Authors:  Majid Zaki Dizaji; Mohsen Malehmir; Ardeshir Ghavamzadeh; Kamran Alimoghaddam; Seyed H Ghaffari
Journal:  Neurochem Res       Date:  2011-10-04       Impact factor: 3.996

3.  Function of carbonic anhydrase IX in glioblastoma multiforme.

Authors:  Martin A Proescholdt; Marsha J Merrill; Eva-Maria Stoerr; Annette Lohmeier; Fabian Pohl; Alexander Brawanski
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

4.  Adverse fetal and neonatal outcomes associated with a life-long high fat diet: role of altered development of the placental vasculature.

Authors:  Emily K Hayes; Anna Lechowicz; Jim J Petrik; Yaryna Storozhuk; Sabrina Paez-Parent; Qin Dai; Imtiaz A Samjoo; Margaret Mansell; Andree Gruslin; Alison C Holloway; Sandeep Raha
Journal:  PLoS One       Date:  2012-03-19       Impact factor: 3.240

5.  Silencing erythropoietin receptor on glioma cells reinforces efficacy of temozolomide and X-rays through senescence and mitotic catastrophe.

Authors:  Elodie A Pérès; Aurélie N Gérault; Samuel Valable; Simon Roussel; Jérôme Toutain; Didier Divoux; Jean-Sébastien Guillamo; Marc Sanson; Myriam Bernaudin; Edwige Petit
Journal:  Oncotarget       Date:  2015-02-10

Review 6.  Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity.

Authors:  Ivy A W Ho; Winston S N Shim
Journal:  Biomed Res Int       Date:  2017-05-28       Impact factor: 3.411

7.  Absence of GAPDH regulation in tumor-cells of different origin under hypoxic conditions in - vitro.

Authors:  Harun M Said; Buelent Polat; Carsten Hagemann; Jelena Anacker; Michael Flentje; Dirk Vordermark
Journal:  BMC Res Notes       Date:  2009-01-13

8.  GAPDH is not regulated in human glioblastoma under hypoxic conditions.

Authors:  Harun M Said; Carsten Hagemann; Jelena Stojic; Beate Schoemig; Giles H Vince; Michael Flentje; Klaus Roosen; Dirk Vordermark
Journal:  BMC Mol Biol       Date:  2007-06-27       Impact factor: 2.946

9.  Nuclear motility in glioma cells reveals a cell-line dependent role of various cytoskeletal components.

Authors:  Alexa Kiss; Peter Horvath; Andrea Rothballer; Ulrike Kutay; Gabor Csucs
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

Review 10.  Prognostic Significance of Carbonic Anhydrase IX Expression in Cancer Patients: A Meta-Analysis.

Authors:  Simon J A van Kuijk; Ala Yaromina; Ruud Houben; Raymon Niemans; Philippe Lambin; Ludwig J Dubois
Journal:  Front Oncol       Date:  2016-03-29       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.